ARCHIVES

Ethics Commission To Continue Consideration Of Compensation For Injured Research Subjects

This article is from The Cancer Letter archive.

Vol. 06 No. 25 | June 20, 1980

Download PDF Visit The Full Archive

Related Articles

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002

Smoking Commission Outlines All-Out War On Cigarettes

February 3, 1978

NCI’s Drug Screen Tests 400 Agents A Week; Recompetition Of Contracts Approved

February 26, 1993

NCI’s Independence To Be Challenged By Edwards When Cancer Act Comes Up For Renewal Next Year

December 21, 1973

DRCCA Organization To Include Three Programs, With Centers In One

August 8, 1980